Tumor-Infiltrating Programmed Death Receptor-1+ Dendritic Cells Mediate Immune Suppression in Ovarian Cancer
James Krempski(Mayo Clinic), Keith L. Knutson(Mayo Clinic)
Cited by 241
Related Papers
Immune-Induced Epithelial to Mesenchymal Transition <i>In vivo</i> Generates Breast Cancer Stem Cells
|Cancer Research|2009|378
Th17-inducing dendritic cell vaccines stimulate effective CD4 T cell-dependent antitumor immunity in ovarian cancer that overcomes resistance to immune checkpoint blockade
|Journal for ImmunoTherapy of Cancer|2023|23
IL-4–STAT6 axis amplifies histamine-induced vascular endothelial dysfunction and hypovolemic shock
|Journal of Allergy and Clinical Immunology|2024|10